David Ilson

6PUBLICATIONS
80CO-AUTHORS
Cancer geneticsChemotherapyHaematological tumoursSocial epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer.

Henry S Walch, Raktim Borpatragohain, Justin Jee

|Feb 13, 2025
KEYNOTE-585: disappointing results for perioperative pembrolizumab in gastric cancer.

David H Ilson

|Oct 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.

Emily C Harrold, Michael B Foote, Benoit Rousseau

|Sep 12, 2023
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.

Melissa A Lumish, Henry Walch, Steven B Maron

|Jul 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.

Samuel J Klempner, Keun-Wook Lee, Kohei Shitara

|Jul 05, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.

Steven B Maron, Walid Chatila, Henry Walch

Pageof 1

Frequent Collaborators

4 joint publications

Henry Walch

3 joint publications

Walid Chatila

3 joint publications

Geoffrey Yuyat Ku

2 joint publications

Steven B Maron